Publications by authors named "Rob L Jansen"

Claim this Profile
S
Severe fluoropyrimidine toxicity due to novel and rare DPYD missense mutations, deletion and genomic amplification affecting DPD activity and mRNA splicing.
André B P van Kuilenburg, Judith Meijer, Dirk Maurer, Doreen Dobritzsch, Rutger Meinsma, Rob L H Jansen

Biochim Biophys Acta Mol Basis Dis· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Systemic Therapy Concurrent With Cranial Radiotherapy for Cerebral Metastases of Solid Tumors.
Maikel Verduin, Jaap D Zindler, Hanneke M A Martinussen, Rob L H Jansen, Sander Croes

Oncologist· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I-II study on the combination of rapamycin and short course radiotherapy in rectal cancer.
Jeroen Buijsen, Jørgen van den Bogaard, Barry Jutten, Eric Belgers, Meindert Sosef, Rob L H Jansen

Radiother Oncol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group.
Lieke H J Simkens, Harm van Tinteren, Anne May, Albert J ten Tije, Geert-Jan M Creemers, Rob L H Jansen

Lancet· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial.
Ninos Ayez, Eric P van der Stok, Hans de Wilt, Sandra A Radema, Richard van Hillegersberg, Rob L Jansen

BMC Cancer· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial.
Walter Taal, Hendrika M Oosterkamp, Annemiek M E Walenkamp, Hendrikus J Dubbink, Laurens V Beerepoot, Rob L H Jansen

Lancet Oncol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of extended versus limited indications for patients undergoing a liver resection for colorectal cancer liver metastases.
Ronald M van Dam, Toine M Lodewick, Maartje A J van den Broek, Mechteld C de Jong, Jan Willem Greve, Rob L H Jansen

HPB (Oxford)· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma.
Sander Kelderman, Bianca Heemskerk, Harm van Tinteren, Rob R H van den Brom, Geke A P Hospers, Rob L Jansen

Cancer Immunol Immunother· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O).
Sander Kelderman, Monique K van der Kooij, Alfons J M van den Eertwegh, Patricia M M B Soetekouw, Rob L H Jansen

Acta Oncol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyaluronic acid as a marker of hepatic sinusoidal obstruction syndrome secondary to oxaliplatin-based chemotherapy in patients with colorectal liver metastases.
Maartje A J van den Broek, Celien P H Vreuls, Ali Winstanley, Rob L H Jansen, Annemarie A van Bijnen

Ann Surg Oncol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of the combination of the Akt inhibitor nelfinavir and chemoradiation for locally advanced rectal cancer.
Jeroen Buijsen, Guido Lammering, Rob L H Jansen, Geerard L Beets, Jaap Wals

Radiother Oncol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Which way is forward in the treatment of rectal cancer?
Rob L H Jansen, Geerard L Beets

Nat Rev Clin Oncol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer.
Monique Maas, Regina G H Beets-Tan, Doenja M J Lambregts, Guido Lammering, Patty J Nelemans, Rob L H Jansen

J Clin Oncol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MRI after chemoradiotherapy of rectal cancer: a useful tool to select patients for local excision.
Sanne M E Engelen, Regina G H Beets-Tan, Max J Lahaye, Guido Lammering, Rob L H Jansen

Dis Colon Rectum· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weekly infusional high-dose fluorouracil (HD-FU), HD-FU plus folinic acid (HD-FU/FA), or HD-FU/FA plus biweekly cisplatin in advanced gastric cancer: randomized phase II trial 40953 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group and the Arbeitsgemeinschaft Internistische Onkologie.
Manfred P Lutz, Hansjochen Wilke, D J Theo Wagener, Udo Vanhoefer, Krzysztof Jeziorski, Rob L Jansen

J Clin Oncol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetic screening of CYP3A and ABCB1 in relation to population pharmacokinetics of docetaxel.
Tessa M Bosch, Alwin D R Huitema, Valerie D Doodeman, Robert Jansen, Els Witteveen, Rob L Jansen

Clin Cancer Res· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and immunohistochemical analysis of patients with unknown primary tumour. A search for prognostic factors in UPT.
Agnès J van de Wouw, Rob L H Jansen, Arjan W Griffioen, Harry F P Hillen

Anticancer Res· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis